Use of 4-imidazole derivatives for CNS disorders

Details for Australian Patent Application No. 2007209380 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Stalder, Henri; Groebke Zbinden, Katrin; Hoener, Marius; Norcross, Roger; Galley, Guido

Agent Spruson & Ferguson

Pub. Number AU-B-2007209380

PCT Pub. Number WO2007/085556

Priority 06100938.7 27.01.06 EP

Filing date 17 January 2007

Wipo publication date 2 August 2007

Acceptance publication date 8 December 2011

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4174 (2006.01)

A61K 31/4178 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

7 August 2008 PCT application entered the National Phase

  PCT publication WO2007/085556 Priority application(s): WO2007/085556

8 December 2011 Application Accepted

  Published as AU-B-2007209380

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007209381-Use of substituted 2-imidazole of imidazoline derivatives

2007209377-A composition for surface colouration of paper